Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
03.08.2023 - Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today reported financial results for the second quarter ended ...
Source: wallstreet-online.de